Clinical Trials on Type 2 Diabetes, Chronic Kidney Disease

Total 22704 results

Imperial College London

Completed

Assessment of the Accuracy of Continuous Glucose Sensors in People With Diabetes Undergoing Haemodialysis (ALPHA)

Chronic Kidney Diseases | Diabetic Nephropathies | Type 1 Diabetes Mellitus

United Kingdom
Omar Tarek Elfarargi

Not yet recruiting

Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease (SGLT2i VS ACEi)

Diabetic Nephropathy Type 2
Brigham and Women's Hospital
Patient-Centered Outcomes Research Institute

Recruiting

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD)

Type2Diabetes | ASCVD

United States
Amsterdam UMC, location VUmc

Withdrawn

REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations (REGROUP)

Diabetes Mellitus, Type 2 | Chronic Kidney Diseases
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Type 2 Diabetes Mellitus With Diabetic Nephropathy

United States
Karolinska University Hospital

Completed

Effect of Acute Fructose Load in Human

Diabetes Mellitus, Type 2 | Chronic Kidney Diseases

Sweden
Bayer
LMC Diabetes & Endocrinology

Completed

Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D) (AWARE-CKD)

Renal Insufficiency, Chronic

Canada
Chinese University of Hong Kong

Completed

Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With Nephropathy

Type 2 Diabetes Mellitus | DM Nephropathy

China
Renalytix AI, Inc.

Active, not recruiting

Prospective Decision Impact Clinical Utility Trial of KidneyIntelX

Chronic Kidney Diseases | Diabetic Kidney Disease | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1

United States
People's Hospital of Zhengzhou University

Completed

PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy

T2DM (Type 2 Diabetes Mellitus)
Bayer

Completed

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone (ARTS-HF)

Heart Failure

France, Taiwan, United States, Turkey, Spain, Greece, Portugal, Germany, Canada, Austria, Czechia, Denmark, Israel, Korea, Republic of, Poland, South Africa, Sweden, Bulgaria, Italy, Finland, Hungary, Lithuania, Netherlands, Australia, ...
Bayer

Completed

Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone (ARTS-HF Japan)

Heart Failure

Japan
Renalytix AI, Inc.

Active, not recruiting

Prospective Decision Impact Trial of KidneyIntelX

Diabetic Kidney Disease | Chronic Kidney Disease, Stage 3 (Moderate) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1

United States
University of Alberta

Recruiting

Home-based Interventions for FrAilty preveNTion in AdultS With DIabeTes and Chronic Kidney Disease (Fantastic)

Kidney Diseases | Frailty | Diabetes Type 2

Canada
Bayer

Completed

An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results (FLAMINGO)

Type 2 Diabetes | Chronic Kidney Disease

United States
Biogen

Terminated

A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes

Type 2 Diabetes | Chronic Kidney Disease
University of Florida
Scott R. MacKenzie Foundation

Completed

Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus

Coronary Artery Disease (CAD) | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD)

United States
Bayer

Completed

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)

Diabetic Nephropathies

Japan
Bayer

Completed

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN)

Diabetic Nephropathies

Hong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
Okayama University

Completed

Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy

Type 2 Diabetes Mellitus | Diabetic Nephropathy

Japan
Chongqing Medical University

Active, not recruiting

Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria

Diabetic Nephropathy

China
Steno Diabetes Center Copenhagen
Department of Clinical Physiology, Nuclear Medicine and PET at Rigshospitalet... and other collaborators

Active, not recruiting

Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe (DiaKidZ)

Diabetes Mellitus, Type 2 | Diabetic Kidney Disease

Denmark
University of Campania "Luigi Vanvitelli"

Completed

Nephropathy In Type 2 Diabetes and Cardio-renal Events (NID-2)

Diabetic Nephropathy

Italy
Assiut University

Unknown

Doppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus.

Diabetic Nephropathies
Brigham and Women's Hospital
Bayer

Recruiting

Decision Support for Detection of Chronic Kidney Disease in Type II Diabetes Mellitus (CKD-DETECT)

Chronic Kidney Diseases | Type2Diabetes

United States
Al-Azhar University

Unknown

Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy ((NAC))

Diabetes Mellitus, Type 2 | Diabetic Kidney Disease | Diabetic Nephropathies

Egypt
Melbourne Health

Completed

Vascular Reactivity in Kidney Disease Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Kidney Failure, Chronic

Australia
Geisinger Clinic

Terminated

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy (RAISE-KT)

Obesity | Diabetic Kidney Disease | Type 2 Diabetes Mellitus in Obese | CKD | Severe Obesity

United States
Novo Nordisk A/S

Recruiting

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

Obesity | Type 2 Diabetes | Chronic Kidney Disease

United States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Hungary, Brazil, Slovakia
Amsterdam UMC, location VUmc

Completed

Renohemodynamic Effects of Combined empagliflOzin and LosARtan (RECOLAR)

Diabetes Mellitus, Type 2 | Diabetic Kidney Disease

Netherlands
NYU Langone Health

Completed

Lifestyle Management of CKD in Obese Diabetic Patients

Obesity | Type 2 Diabetes | Chronic Kidney Disease (CKD)

United States
Mesoblast, Ltd.

Completed

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

Diabetic Nephropathy | Type 2 Diabetes

Australia
Novartis

Completed

Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

Diabetes Type 2

Denmark
Peter Rossing

Completed

Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes (DapKid)

Diabetic Nephropathy | Type 2 Diabetes

Denmark
Coordinación de Investigación en Salud, Mexico
Baxter Healthcare Corporation

Not yet recruiting

Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis

Peritoneal Dialysis | Diabetes Mellitus Type 2 | Kidney Disease, Chronic
Bayer

Recruiting

A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients (SMART-Finder)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Germany
Bayer

Active, not recruiting

An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions (FIRST-2)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

United States
Bayer

Recruiting

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions (FINEROD)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Germany, Japan
Bayer

Recruiting

A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus | Chronic Kidney Disease

India
Bayer

Recruiting

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Type 2 Diabetes Mellitus | Chronic Kidney Disease

United States, Germany, Argentina, Belgium, Brazil, Canada, Chile, Colombia, France, Italy, Korea, Republic of, Luxembourg, Mexico, Netherlands, Russian Federation, Saudi Arabia, Singapore, Slovenia, Spain, Switzerland, Taiwan, Th... and more
Bayer

Completed

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants (FIGARO-BM)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Spain, Belgium, United States, Russian Federation, Hong Kong, Singapore, Taiwan, Korea, Republic of, Canada, Austria, Italy, Japan, Denmark, Australia, Bulgaria, Czechia, Finland, Israel, Netherlands, Sweden, Portugal
Duke University
Boehringer Ingelheim

Recruiting

Optimizing In-hospital Use of Evidence-based Therapies for Patients With Cardio-Renal-Metabolic Disease (IMPLEMENT-CRM)

Heart Failure | Chronic Kidney Diseases | Type 2 Diabetes

United States
Merck Sharp & Dohme LLC

Completed

A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)

Type 2 Diabetes Mellitus | Chronic Renal Insufficiency
Merck Sharp & Dohme LLC

Completed

An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)

Diabetes Mellitus, Type 2 | Chronic Renal Insufficiency
Kaiser Permanente

Completed

Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk (KP NOURISH)

Heart Failure | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases

United States
Tehran University of Medical Sciences

Completed

Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure

Type 2 Diabetes Mellitus | Diabetic Nephropathy | Essential Hypertension

Iran, Islamic Republic of
Karolinska Institutet
Lantmännen

Completed

Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2 (INITIATE)

Diabetes Mellitus, Type 2 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3B

Sweden
Pfizer

Completed

A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

Diabetic Nephropathy

United States, Spain, Korea, Republic of, Australia, Hong Kong, Germany, Poland, Italy, Canada, Puerto Rico, Malaysia, Romania, Argentina, Peru
RWTH Aachen University

Completed

Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease

End Stage Renal Disease | Diabetes Mellitus Type 2

Germany
Eli Lilly and Company

Recruiting

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD)

Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | T2D

United States, Mexico, Canada, Austria, Netherlands, Denmark

Clinical Trials on Type 2 Diabetes, Chronic Kidney Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations